Navigation Links
VerifyNow in Medical News

Accumetrics' VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient's Response to Newly-Approved Prasugrel (Effient(R))

...el (Effient), Accumetrics, Inc. announces that its verifynow P2Y12 Test is not only able to assess response to ...ompetitor, Effient. In obtaining a result from the verifynow System, physicians are provided objective informat...ll, President and CEO of Accumetrics. "We feel the verifynow System can dramatically contribute to a physician'...

Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus

...Medtechnica, Ltd. will oversee distribution of all verifynow products in Israel, while Z.S. Curemed, Ltd. will ...tes and Europe where physicians have access to the verifynow System. The verifynow System assesses response to antiplatelet therapies...

Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial

..., identified based on the results of the company's verifynow P2Y12 Test, reduces major cardiovascular adverse e...oser to our goal of demonstrating the value of the verifynow System. By identifying and adjusting therapy for p...edicine and improved outcomes. We believe that the verifynow System will be seen as an integral tool in ensurin...

Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited

...nt with ELITech UK Limited for distribution of the verifynow System in the United Kingdom. The distribution ag...ng our global presence." "Distribution of the verifynow System is extremely complementary to our current p...Tim Watson, Managing Director of ELITech UK. "The verifynow System is an excellent fit with our expertise with...

Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.

...id platelet function assessment. Accumetrics' verifynow System is the first rapid and easy to use platform...irin, Plavix(R), ReoPro(R), and Integrilin(R), the verifynow System provides a valuable tool to help physicians...ed treatment decisions. The Accumetrics logo and verifynow are registered trademarks of Accumetrics, Inc. Reo...

Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.

...-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the verifynow System provides a valuable tool to help physicians make informed treatment decisions. The Accumetrics logo and verifynow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trade...

Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D

...(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions. The Accumetrics logo and verifynow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium P...

Half of patients undergoing cerebrovascular stent placement respond poorly to clopidogrel

...erwent cerebrovascular stent placement for various clinical indications, including wide-neck aneurysm and intracranial stenosis. Researchers used the verifynow rapid platelet function assay-aspirin (RPFA-ASA) to calculate aspirin reaction units and the P2Y12 assay (VerifyNow) to calculate P2Y12 reaction units...

Aspirin Therapy for Heart Disease Found More Effective for Men Than Women

...t for a regularly scheduled appointment. All had coronary artery disease but only half had a history of heart attack. Researchers used a device called verifynow Aspirin Assay to test the percentage of platelet reactivity after blood samples were exposed to a chemical that causes clotting. Aspirin works b...
VerifyNow in Medical Technology

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

..., identified based on the results of the company's verifynow P2Y12 Test, reduces major cardiovascular adverse e.... We continue our commitment to ensuring that the verifynow System is shown to be an integral tool in optimizi...elet therapy based on the results of the company's verifynow System and P2Y12 Test reduces major cardiovascular...

Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial

...VITAS trial is designed to evaluate the use of the verifynow P2Y12 test to identify patients that exhibit a low...'s response to clopidogrel as determined using the verifynow P2Y12 test. The GRAVITAS trial is a double-blind...cebo-controlled, randomized trial that employs the verifynow P2Y12 test to classify patients undergoing percuta...

Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial

...al, called GRAVITAS (Gauging Responsiveness With A verifynow Assay-Impact On Thrombosis And Safety) to establish platelet function testing with verifynow as the standard of care. The Executive Committee c...ristopher Cannon, MD. "The GRAVITAS trial, using verifynow to gauge patients' response is prototypic of the f...
VerifyNow in Medical Products

VerifyNow (Ultegra) System

Description:... The verifynow (Ultegra) System is a turbidimetric based optical detection system which measures platelet induced aggregation as an increase in light transmittance. ...
Company:Accumetrics

VerifyNow Clopidogrel Assay

Description:... The verifynow Clopidogrel Assay measures changes in platelet function in response to patients taking Clopidogrel (Plavix). It uses a specific activator for the P2Y1...
Company:Accumetrics

VerifyNow IIb/IIIa Assay

Description:... The verifynow IIb/IIIa Assay is an automated, turbidimetric, whole- blood assay designed ...ted platelets to bind to fibrinogen coated beads. The detection well of the verifynow IIb/IIIa assay device contains all of the necessary reagents to perform thi...
Company:Accumetrics

VerifyNow Aspirin Assay

Description:...nefits. These people are at greater risk for a heart attack or stroke. The verifynow Aspirin Assay is a qualitative test to aid in the detection of platelet dys... in citrated whole blood for the point of care or laboratory setting. The verifynow System is a turbidimetric based optical detection system which measures pla...
Company:Accumetrics

VerifyNow System

Description:... The Company's first commercial product is the verifynow System, a point-of-care, bedside instrument with s..., disposable assay devices . The advantages of the verifynow System over previous products are direct use of a ...tube (whole blood sample) and a result in minutes. verifynow IIb/IIIa, the first assay developed for use on the...
Company:Accumetrics
VerifyNow in Biological Technology

Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg

... European countries. Distribution of Accumetrics' verifynow products will be handled by AAZ in France; BITmedi...a in the Netherlands, Belgium and Luxembourg. The verifynow System assesses response to life-saving antiplatel...bal expansion of our distribution strategy for the verifynow System. Accumetrics has chosen each of these part...

Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics

...-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the verifynow System provides a valuable tool to help physicians make informed treatment decisions. The Accumetrics logo and verifynow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trade...

Accumetrics Appoints John J. Young, MD Chief Medical Officer

...(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions. The Accumetrics logo and verifynow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium ...

Timothy I. Still Appointed CEO at Accumetrics

...ic tests for rapid platelet function assessment. verifynow is the first simple and rapid system for measuring...irin, Plavix(R), ReoPro(R), and Integrilin(R), the verifynow system provides a valuable tool to help physicians...ed treatment decisions. The Accumetrics logo and verifynow are registered trademarks of Accumetrics, Inc., Re...
Other Tags
(Date:7/13/2014)... By Serena Gordon ... -- A new type of sensor for people with ... body using saliva instead of blood, researchers report. Scientists ... successfully tested it using artificial saliva. It uses light, metal ... blood sugar. "Everybody knows that diabetics have to prick ...
(Date:7/13/2014)... July 13, 2014 Athletes with a ... period from concussions, according to research presented today at ... ) Annual Meeting. The research marks the first of ... on the known physical events that occur after a ... a long allele in the (GT)n genotype were four ...
(Date:7/13/2014)... 13, 2014 Recently, 2014QuinceaneraDresses.com, the ... unveiled its new range of gorgeous Quinceanera ... the demand for elegant Quinceanera outfits is huge. ... items. All the company’s newly released dresses are ... are all elegant and vivid. , It ...
(Date:7/13/2014)... Recently, MyDressCity.com, one of the most popular suppliers of ... its new range of elegant Quinceanera dresses . ... discounted prices. Worldwide clients can enjoy this special offer ... online shop, there are plenty of beautiful dresses for ... materials. MyDressCity.com’s hot items are prom gowns, bridesmaid gowns, ...
(Date:7/13/2014)... July 13, 2014 Epidemiologists forecast an ... the 6MM, from 8,062 diagnosed incident cases in 2013 ... Annual Growth Rate (AGR) of 4.35%, during the forecast ... number of diagnosed incident cases of aGVHD in the ... have the lowest number of diagnosed incident cases of ...
Breaking Medicine News(10 mins):Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 2Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 3Health News:Graft-Versus-Host Disease Market (GVHD) Growing at 4.35% AGR to 2023 Says a New Report Available at ReportsnReports.com 4
(Date:7/11/2014)... cannabinoid receptor type 1 can inhibit voltage-gated ... reduce neurotransmitter release. However, some scholars demonstrated ... extracellular Ca2+ influx and increase neurotransmitter release. ... Hospital Affiliated to Tongji Medical College, Huazhong ... whole cell voltage-clamp and calcium imaging in ...
(Date:7/10/2014)... Albuquerque, and other major cities in New Mexico, nearly ... municipal wastewater rather than precious potable water supplies. Across ... of all golf courses receive treated effluent. Reusing the ... Additionally, golf courses and homeowners alike fertilize their lawns ... is nitrate. A New Mexico State University turfgrass expert ...
(Date:7/10/2014)... 1, 2014 Smart technology emphasis grows ... and improved security: NXT-ID, Inc. (OTCBB: NXTD), eBay Inc. (NASDAQ: ... ), Apple Inc. (NASDAQ: AAPL ), Visa Inc. ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused ... the second series of 30 second spots on CNBC for ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
Other Contents